Abstract
This study first investigates the chemical composition and biological activities of essential oils extracted from the stem barks and leaves of Bougainvillea glabra Choisy cultivated in Vietnam. The gas chromatography-mass spectrometry (GC-MS) analysis revealed cis-phytol as the major compound, especially in the leaf essential oil (75.5%). Both essential oils exhibited notable cytotoxicity against HepG2 cells, with the stem bark oil showing stronger effects. The samples also displayed significant antioxidant activity, xanthine oxidase (XO) inhibition, nitric oxide (NO) suppression, and enzyme inhibitory properties against α-glucosidase, protein tyrosine phosphatase 1B (PTP1B), and acetylcholinesterase (AChE), with the leaf oil generally outperforming the stem bark oil. B. glabra showed anti-inflammation via the inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expressions. Especially, the studied oils (IC50 198.43-227.18 µg/mL) are better than the standard acarbose (IC50 241.76 µg/mL) against the α-glucosidase enzyme. Antimicrobial assays revealed moderate inhibition of two samples against both Gram (+) and Gram (-) bacteria, but limited antifungal activity. The findings were further supported by computational analyses. Molecular docking and toxicity prediction of the three major oil constituents, linalool, cis-phytol, and neophytadiene, revealed notable binding affinities to α-glucosidase and favorable safety profiles.
Keywords:
Bougainvillea glabra; biological activity; computation; essential oil.
© 2025 Wiley‐VHCA AG, Zurich, Switzerland.
MeSH terms
-
Acetylcholinesterase / metabolism
-
Anti-Inflammatory Agents / chemistry
-
Anti-Inflammatory Agents / isolation & purification
-
Anti-Inflammatory Agents / pharmacology
-
Antioxidants* / chemistry
-
Antioxidants* / isolation & purification
-
Antioxidants* / pharmacology
-
Cell Survival / drug effects
-
Cyclooxygenase 2 / metabolism
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / isolation & purification
-
Enzyme Inhibitors / pharmacology
-
Glycoside Hydrolase Inhibitors / chemistry
-
Glycoside Hydrolase Inhibitors / isolation & purification
-
Glycoside Hydrolase Inhibitors / pharmacology
-
Hep G2 Cells
-
Humans
-
Microbial Sensitivity Tests
-
Molecular Docking Simulation
-
Molecular Structure
-
Nitric Oxide / antagonists & inhibitors
-
Nitric Oxide / biosynthesis
-
Nitric Oxide Synthase Type II / antagonists & inhibitors
-
Nitric Oxide Synthase Type II / metabolism
-
Oils, Volatile* / chemistry
-
Oils, Volatile* / isolation & purification
-
Oils, Volatile* / pharmacology
-
Plant Bark / chemistry
-
Plant Bark / metabolism
-
Plant Leaves / chemistry
-
Plant Leaves / metabolism
-
Plant Stems / chemistry
-
Plant Stems / metabolism
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / antagonists & inhibitors
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
-
Structure-Activity Relationship
-
Xanthine Oxidase / antagonists & inhibitors
-
Xanthine Oxidase / metabolism
-
alpha-Glucosidases / metabolism
Substances
-
Oils, Volatile
-
alpha-Glucosidases
-
Nitric Oxide
-
Antioxidants
-
Acetylcholinesterase
-
Xanthine Oxidase
-
Cyclooxygenase 2
-
Protein Tyrosine Phosphatase, Non-Receptor Type 1
-
Nitric Oxide Synthase Type II
-
Anti-Inflammatory Agents
-
Glycoside Hydrolase Inhibitors
-
Enzyme Inhibitors